Ahead of World Malaria Day on April 25, the World Health Organisation (WHO) announced a significant step forward in the fight against malaria with the pre-qualification of the first treatment developed specifically for newborns and young infants weighing between two and five kilograms. The pre-qualification designation indicates that the medicine meets international standards of quality, safety and efficacy, and will help to expand access to quality-assured treatment for one of the most underserved patient groups.
